[MYGN] YoY Annual Result on 30-Jun-2017 [#FY]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
09-Aug-2017
Financial Year
2016
Quarter
30-Jun-2017 [#FY]
Profit Trend
YoY- -82.60%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Annual Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 851,100 851,100 772,600 771,400 753,800 723,100 778,216 1.50%
PBT 200 7,700 116,900 42,900 168,900 134,900 277,865 -70.03%
Tax -4,400 -4,400 -13,900 21,300 43,600 54,700 101,640 -
NP 4,600 4,600 131,000 21,800 125,300 80,200 176,225 -45.50%
Tax Rate 2,200.00% 57.14% 11.89% -49.65% -25.81% -40.55% -36.58% -
Total Cost 846,500 846,500 641,600 749,600 628,500 642,900 601,991 5.84%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin 0.54 0.54 16.96 2.83 16.62 11.09 22.64 -46.31%
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS 0.06 0.06 1.89 0.32 1.79 1.12 2.33 -45.62%
EPS Diluted 0.06 0.06 1.82 0.32 1.71 1.08 2.25 -45.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.